Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Moore

Showing results (181-190 of 320) with videos related to

Pageof 32
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2009
Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potencyPaolo Ingallinella, Elisabetta Bianchi, Neal A Ladwa, et al.
Journal of Virology|August 7, 2002
Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1Rogier W Sanders, Mika Vesanen, Norbert Schuelke, et al.
Molecules (Basel, Switzerland)|February 5, 2021
The Influence of Hydrolytic Enzymes on Tannin Adsorption-Desorption onto Grape Cell Walls in a Wine-Like MatrixAndrea Osete-Alcaraz, Encarna Gómez-Plaza, Pilar Martínez-Pérez, et al.
European Journal of Immunology|July 22, 2014
Independent evolution of Fc- and Fab-mediated HIV-1-specific antiviral antibody activity following acute infectionAnne-Sophie Dugast, Leonidas Stamatatos, Andrew Tonelli, et al.
Food Research International (Ottawa, Ont.)|February 11, 2020
The impact of carbohydrate-active enzymes on mediating cell wall polysaccharide-tannin interactions in a wine-like matrixAndrea Osete-Alcaraz, Encarna Gómez-Plaza, Pilar Martínez-Pérez, et al.
Elife|January 13, 2021
High-resolution mapping of the neutralizing and binding specificities of polyclonal sera post-HIV Env trimer vaccinationAdam S Dingens, Payal Pratap, Keara Malone, et al.
Nature Immunology|February 27, 2004
HIV vaccine design and the neutralizing antibody problemDennis R Burton, Ronald C Desrosiers, Robert W Doms, et al.
Nature Medicine|February 13, 2003
Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120Ronald S Veazey, Robin J Shattock, Melissa Pope, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2012
Differential use of CCR5 by HIV-1 clinical isolates resistant to small-molecule CCR5 antagonistsTimothy J Henrich, Nicolas R P Lewine, Sun-Hee Lee, et al.
Retrovirology|June 22, 2011
A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cellsMark Melchers, Katie Matthews, Robert P de Vries, et al.
Pageof 32

Showing results (181-190 of 320) with videos related to

Sort By:
Pageof 32
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2009
Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potencyPaolo Ingallinella, Elisabetta Bianchi, Neal A Ladwa, et al.
Journal of Virology|August 7, 2002
Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1Rogier W Sanders, Mika Vesanen, Norbert Schuelke, et al.
Molecules (Basel, Switzerland)|February 5, 2021
The Influence of Hydrolytic Enzymes on Tannin Adsorption-Desorption onto Grape Cell Walls in a Wine-Like MatrixAndrea Osete-Alcaraz, Encarna Gómez-Plaza, Pilar Martínez-Pérez, et al.
European Journal of Immunology|July 22, 2014
Independent evolution of Fc- and Fab-mediated HIV-1-specific antiviral antibody activity following acute infectionAnne-Sophie Dugast, Leonidas Stamatatos, Andrew Tonelli, et al.
Food Research International (Ottawa, Ont.)|February 11, 2020
The impact of carbohydrate-active enzymes on mediating cell wall polysaccharide-tannin interactions in a wine-like matrixAndrea Osete-Alcaraz, Encarna Gómez-Plaza, Pilar Martínez-Pérez, et al.
Elife|January 13, 2021
High-resolution mapping of the neutralizing and binding specificities of polyclonal sera post-HIV Env trimer vaccinationAdam S Dingens, Payal Pratap, Keara Malone, et al.
Nature Immunology|February 27, 2004
HIV vaccine design and the neutralizing antibody problemDennis R Burton, Ronald C Desrosiers, Robert W Doms, et al.
Nature Medicine|February 13, 2003
Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120Ronald S Veazey, Robin J Shattock, Melissa Pope, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2012
Differential use of CCR5 by HIV-1 clinical isolates resistant to small-molecule CCR5 antagonistsTimothy J Henrich, Nicolas R P Lewine, Sun-Hee Lee, et al.
Retrovirology|June 22, 2011
A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cellsMark Melchers, Katie Matthews, Robert P de Vries, et al.
Pageof 32